Lantheus Holdings Total Non-Cash Items 2013-2025 | LNTH
Lantheus Holdings annual/quarterly total non-cash items history and growth rate from 2013 to 2025. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
- Lantheus Holdings total non-cash items for the quarter ending March 31, 2025 were $0.053B, a 481.81% increase year-over-year.
- Lantheus Holdings total non-cash items for the twelve months ending March 31, 2025 were $0.465B, a 10.14% increase year-over-year.
- Lantheus Holdings annual total non-cash items for 2024 were $0.23B, a 53.71% increase from 2023.
- Lantheus Holdings annual total non-cash items for 2023 were $0.15B, a 54.44% decline from 2022.
- Lantheus Holdings annual total non-cash items for 2022 were $0.329B, a 134.26% increase from 2021.
| Lantheus Holdings Annual Total Non-Cash Items (Millions of US $) |
|
|---|---|
| 2024 | $230 |
| 2023 | $150 |
| 2022 | $329 |
| 2021 | $140 |
| 2020 | $52 |
| 2019 | $40 |
| 2018 | $35 |
| 2017 | $-60 |
| 2016 | $21 |
| 2015 | $45 |
| 2014 | $27 |
| 2013 | $57 |
| 2012 | $46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $5.242B | $1.534B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.294B | 27.81 |
| Boston Scientific (BSX) | United States | $157.073B | 39.32 |
| Stryker (SYK) | United States | $146.485B | 30.63 |
| EssilorLuxottica (ESLOY) | France | $131.510B | 0.00 |
| Medtronic (MDT) | Ireland | $104.117B | 14.76 |
| Haleon (HLN) | United Kingdom | $50.587B | 28.80 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.544B | 0.00 |
| ResMed (RMD) | United States | $36.103B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $32.514B | 15.44 |
| Agilent Technologies (A) | United States | $31.721B | 20.95 |
| Terumo (TRUMY) | Japan | $28.131B | 36.54 |
| Insulet (PODD) | United States | $22.987B | 90.23 |
| Koninklijke Philips (PHG) | Netherlands | $21.694B | 15.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.639B | 11.97 |
| Baxter (BAX) | United States | $15.842B | 11.83 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.666B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.269B | 21.81 |
| Prestige Consumer Healthcare (PBH) | United States | $4.244B | 18.96 |
| Perrigo (PRGO) | Ireland | $3.757B | 9.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.266B | 14.88 |
| ICU Medical (ICUI) | United States | $3.210B | 23.67 |
| Envista Holdings (NVST) | United States | $3.051B | 25.35 |
| GN Store Nord (GNNDY) | Denmark | $2.163B | 17.92 |
| QuidelOrtho (QDEL) | United States | $2.114B | 14.54 |
| LeMaitre Vascular (LMAT) | United States | $1.868B | 41.76 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Neogen (NEOG) | United States | $1.335B | 17.08 |
| Acuren (TIC) | United States | $1.317B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.256B | 12.75 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Evolus (EOLS) | United States | $0.633B | 0.00 |
| CeriBell (CBLL) | United States | $0.625B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.590B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Owens & Minor (OMI) | United States | $0.509B | 4.22 |
| Capricor Therapeutics (CAPR) | United States | $0.479B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.446B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.307B | 54.70 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.11 |
| Cerus (CERS) | United States | $0.241B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| Quanterix (QTRX) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.46 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.69 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Agape ATP (ATPC) | $0.092B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.42 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.47 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.86 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |